SWM
AUPH icon

Selective Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Selective Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,500
Closed -$15K – 758
2022
Q2 		$15K Hold
1,500
– – 0.01% 505
2022
Q1 		$19K Hold
1,500
– – 0.01% 451
2021
Q4 		$34K Hold
1,500
– – 0.01% 330
2021
Q3 		$33K Buy
+1,500
New +$23.8K 0.02% 310

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Selective Wealth Management's AUPH Position: Q3 2022 in Review

Selective Wealth Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2022, closing a stake of 1,500 shares — an estimated $15K sold.

Selective Wealth Management first reported a position in AUPH in Q3 2021 and held it in 4 quarters. The position peaked at $34K in Q4 2021. 189 funds tracked by Wall St. Rank hold AUPH as of Q3 2022.

  • Selective Wealth Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Selective Wealth Management sold 1,500 Aurinia Pharmaceuticals shares in Q3 2022, an estimated $15K.
  • Selective Wealth Management first reported a position in Aurinia Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • Selective Wealth Management's Aurinia Pharmaceuticals position peaked at $34K in Q4 2021.
  • 189 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2022.

Based on Selective Wealth Management's 13F filing for Q3 2022, filed 21 Oct 2022.